März 31, 2025
King & Spalding Secures Victory for The American Clinical Laboratory Association Challenging a Final Rule Issued by the FDA
November 17, 2022
Parallelimport von Arzneimitteln - King & Spalding vertritt Novartis vor dem EuGH
Juni 22, 2022
Cathay Capital Private Equity and 3i Enter into an Agreement to Sell Havea Group to BC Partners
Juli 20, 2016
King & Spalding Advises Jounce Therapeutics on Deal Worth Up to $2.5 Billion
März 24, 2016
King & Spalding Represents GSK on Strategic Collaboration with Miltenyi Biotec
September 17, 2015
King & Spalding Advises Nurix in $150 Million-Plus Drug Collaboration and Option Deal with Celgene
Juni 8, 2015
King & Spalding Team Advises Five Prime Therapeutics in $131 Million License Agreement with bluebird bio
Dezember 5, 2014
King & Spalding Advises Arbor Pharmaceuticals in Minority-Stake Sale to KKR